Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Lundbeck, Zenobia and Vernalis to codevelop dardarin inhibitors

Dec. 17, 2010

Serodus licenses RO-1160367 from Roche

Dec. 17, 2010

Anaphore and Mitsubishi Tanabe Pharma to develop protein therapies for autoimmune disorders

Dec. 15, 2010

Preliminary phase Ib/IIa data presented on ibudilast in opioid addiction

Dec. 15, 2010

Infinity Pharma and Mundipharma extend alliance

Dec. 14, 2010

Forest Labs and Gruenenthal to develop new analgesics GRT-6005 and GRT-6006

Dec. 14, 2010

Prometheus Labs and UCLA study biological markers of mucosal healing in IBD

Dec. 13, 2010

Apexigen and Centocor to collaborate on antibody discovery

Dec. 13, 2010

Baylor Research Institute and Roche partner for immunology research

Dec. 10, 2010

Ascenta and LLS collaborate to develop AT-406

Dec. 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...